MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-25-2026
Aurora Cannabis ROCE Ratio 2011-2026 | ACB
Annual ROCE Ratio Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -23.09 | -6.28 | -4.42 | -3.22 | -44.14 | -71.3 | -22.65 | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.22 | -71.3 | -25.01 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
-10.43 | $ 2.64 | -1.12 % | $ 1.36 B |  Canada |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
58.18 | $ 40.9 | 0.91 % | $ 1.5 B | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 4.36 | 4.06 % | $ 61.3 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 24.44 | -4.12 % | $ 1.13 B | USA |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 7.13 | -1.79 % | $ 624 M | USA |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 5.65 | -1.22 % | $ 2.06 B | Canada |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.13 | 1.8 % | $ 122 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 1.2 | 9.09 % | $ 1.49 M | USA |
 |
Tilray
TLRY
|
-41.31 | $ 6.16 | -1.28 % | $ 3.81 B | Canada |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.42 | 0.71 % | $ 402 M | Canada |
 |
Veru
VERU
|
-114.23 | $ 2.26 | 0.44 % | $ 305 M | USA |
 |
Evolus
EOLS
|
141.36 | $ 5.33 | -1.11 % | $ 344 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.41 | 3.68 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 8.47 | 2.67 % | $ 434 M | USA |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 2.57 | 9.36 % | $ 338 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-235.96 | $ 0.87 | 0.14 % | $ 3.75 M | USA |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
-22.92 | $ 18.47 | 0.22 % | $ 118 M | USA |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 7.64 | 1.6 % | $ 302 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 0.99 | 6.48 % | $ 49.4 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
3.74 | $ 15.04 | 0.67 % | $ 18.1 B | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 0.89 | 1.29 % | $ 32 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.53 | -2.39 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
-16.33 | $ 2.07 | 1.47 % | $ 23.9 M | USA |